Вы и ваши гормоны. Наука о женском здоровье и гормональной контрацепции

95. Zimmerman, Y., Eijkemans, M. J., Bennink, H. J. et al. (2013). The effect of combined oral contraception on testosterone levels in healthy women: A systematic review and meta-analysis. Human Reproduction Update, 20(1), 76–105. doi:10.1093/­humupd/­dmt038; Fern, M., Rose, D. P., & Fern, E. B. (1978). Effect of oral contraceptives on plasma androgenic steroids and their precursors. Obstetrics and Gynecology, 51(5), 541–544. doi:10.1097/­0000­6250-1978­05­000-000­05; Aden, U., Jung-Hoffmann, C., & Kuhl, H. (1998). A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives. Contraception, 58(2), 75–81. doi:10.1016/­s0010-7824­(98)­00071-7; Wiegratz, I., Kutschera, E., Lee, J. et al. (2003). Effect of four different oral contraceptives on various sex hormones and serum-binding globulins. Contraception, 67(1), 25–32. doi:10.1016/­s0010-7824­(02)­00436-5; Ågren, U. M., Anttila, M., Mäenpää-Liukko, K. et al. (2011). Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function. European Journal of Contraception and Reproductive Health Care, 16(6), 458–467. doi:10.3109/­1362­5187.­2011.­614­363.

96. Zimmerman, Y., Eijkemans, M. J., Bennink, H. J. et al. (2013). The effect of combined oral contraception on testosterone levels in healthy women: A systematic review and meta-analysis. Human Reproduction Update, 20(1), 76–105; Vange, N. V., Blankenstein, M., Kloosterboer, H. et al. (1990). Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone. Contraception, 41(4), 345–352. doi:10.1016/­0010-7824­(90)­90034-s; Coenen, C., Thomas, C., Borm, G. et al. (1996). Changes in androgens during treatment with four low-dose contraceptives. Contraception, 53(3), 171–176. doi:10.1016/­0010-7824­(96)­00006-6; Greco, T., Graham, C. A., Bancroft, J. et al. (2007). The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: A comparison of two triphasic formulations containing norgestimate and either 35 or 25μg of ethinyl estradiol. Contraception, 76(1), 8–17. doi:10.1016/­j.contraception.­2007.­04.­002.

97. Aden, U., Jung-Hoffmann, C., & Kuhl, H. (1998). A randomized cross-over study on various hormonal parameters of two triphasic oral contraceptives. Contraception, 58(2), 75–81. doi:10.1016/­s0010-7824­(98)­00071-7; Alexander, G. (1990). Testosterone and sexual behavior in oral contraceptive users and nonusers: A prospective study. Hormones and Behavior, 24(3), 388–402. doi:10.1016/­0018-506x­(90)­90017-r; Wiegratz, I., Jung-Hoffmann, C., & Kuhl, H. (1995). Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins. Contraception, 51(6), 341–346. doi:10.1016/­0010-7824­(95)­00098-u; Coenen, C., Thomas, C., Borm, G. et al. (1996). Changes in androgens during treatment with four low-dose contraceptives. Contraception, 53(3), 171–176. doi:10.1016/­0010-7824­(96)­00006-6; Thorneycroft, I. H., Stanczyk, F. Z., Bradshaw, K. D. et al. (1999). Effect of low-dose oral contraceptives on androgenic markers and acne. Contraception, 60(5), 255–262. doi:10.1016/­s0010-7824­(99)­00093-1; Edwards, D. A., & Oneal, J. L. (2009). Oral contraceptives decrease saliva testosterone but do not affect the rise in testosterone associated with athletic competition. Hormones and Behavior, 56(2), 195–198. doi:10.1016/­j.yhbeh.­2009.­01.­008.